Stephen D. Silberstein focuses on Migraine, Anesthesia, Placebo, Randomized controlled trial and Headaches. His Migraine research integrates issues from Physical therapy, Clinical trial and Pediatrics. His Physical therapy study deals with International Classification of Headache Disorders intersecting with Cluster headache.
The Anesthesia study combines topics in areas such as Frovatriptan, Central nervous system disease, Neurological disorder and Vagus nerve stimulation. His Placebo study combines topics from a wide range of disciplines, such as Tolerability, Severity of illness, Subgroup analysis and Clinical endpoint. His studies examine the connections between Randomized controlled trial and genetics, as well as such issues in Adverse effect, with regards to Surgery.
His primary scientific interests are in Migraine, Anesthesia, Chronic Migraine, Internal medicine and Headaches. He combines subjects such as Tolerability, Adverse effect, Placebo, Physical therapy and Pediatrics with his study of Migraine. He has researched Pediatrics in several fields, including Aura and Topiramate.
His Anesthesia study incorporates themes from Randomized controlled trial, Neurological disorder and Sumatriptan. Stephen D. Silberstein integrates Chronic Migraine with In patient in his study. His research in Nausea intersects with topics in Photophobia and Phonophobia.
Migraine, Chronic Migraine, Internal medicine, Placebo and Tolerability are his primary areas of study. The concepts of his Migraine study are interwoven with issues in Clinical trial, Adverse effect, Randomized controlled trial, Intensive care medicine and Calcitonin gene-related peptide. His Clinical trial research is multidisciplinary, incorporating perspectives in Physical therapy and Pediatrics.
His Chronic Migraine study is related to the wider topic of Anesthesia. Stephen D. Silberstein studies Cluster headache which is a part of Anesthesia. Stephen D. Silberstein has included themes like Nausea, Clinical endpoint and Dosing in his Placebo study.
Stephen D. Silberstein spends much of his time researching Migraine, Internal medicine, Chronic Migraine, Clinical trial and Placebo. His study in Migraine is interdisciplinary in nature, drawing from both Tolerability, Randomized controlled trial, Calcitonin gene-related peptide, Dosing and Headaches. His Chronic Migraine study is concerned with the larger field of Anesthesia.
His work in Anesthesia covers topics such as Vagus nerve stimulation which are related to areas like Cluster headache. His Clinical trial research includes themes of Gastroenterology, Intensive care medicine, Pathophysiology, Headache Disorders and Physical therapy. His work deals with themes such as Nausea, Photophobia, Clinical endpoint and Phonophobia, which intersect with Placebo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The International Classification of Headache Disorders, 3rd edition (beta version)
Jes Olesen;André Bes;Robert Kunkel;James W. Lance.
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
Stephen D. Silberstein.
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
J. Olesen;M -G Bousser;H -C Diener;D. Dodick.
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
HC Diener;DW Dodick;SK Aurora;CC Turkel.
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S.D. Silberstein;S. Holland;F. Freitag;D.W. Dodick.
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora.
Classification of daily and near-daily headaches: Field trial of revised IHS criteria
Stephen D. Silberstein;Richard B. Lipton;Martin John Sliwinski.
Botulinum Toxin Type A as a Migraine Preventive Treatment
Stephen Silberstein;Ninan Mathew;Joel Saper;Stephen Jenkins.
Topiramate in Migraine Prevention: Results of a Large Controlled Trial
Stephen D. Silberstein;Walter Neto;Jennifer Schmitt;David Jacobs.
JAMA Neurology (2004)
Premonitory symptoms in migraine: an electronic diary study.
N. J. Giffin;L. Ruggiero;R. B. Lipton;S. D. Silberstein.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: